Indapamide (Lozol) vs Other Diuretics: Detailed Comparison

  • Home
  • Indapamide (Lozol) vs Other Diuretics: Detailed Comparison
Indapamide (Lozol) vs Other Diuretics: Detailed Comparison
1 October 2025

Indapamide vs Other Diuretics Comparison Tool

Select two drugs and an attribute, then click "Compare" to see their differences.

Key Comparison Criteria

  • Duration of action - Longer‑acting agents reduce the need for twice‑daily dosing.
  • Electrolyte profile - Some diuretics deplete potassium more aggressively.
  • Kidney safety - Certain drugs are safer for patients with reduced GFR.
  • Cost & insurance coverage - Generic availability drives out‑of‑pocket expense.
  • Primary indication - While all lower pressure, some are favored for heart‑failure, others for pure hypertension.

Detailed Drug Attributes

Attribute Indapamide (Lozol) Hydrochlorothiazide Chlorthalidone Furosemide Spironolactone Bumetanide Amiloride
Drug class Thiazide‑like Thiazide Thiazide‑like Loop Potassium‑sparing Loop Potassium‑sparing
Typical daily dose 1.25‑2.5mg 12.5‑50mg 12.5‑25mg 20‑80mg 25‑100mg 0.5‑2mg 5‑10mg
Half‑life 14‑16h 6‑15h 40‑60h 2‑4h 24‑36h 1‑1.5h 6‑9h
Potassium impact Mild loss Moderate loss Moderate loss Significant loss Retains potassium Significant loss Retains potassium
Kidney safety Good (GFR ≥30 mL/min) Moderate (GFR ≥30 mL/min) Good (GFR ≥30 mL/min) Good (GFR ≥30 mL/min) Good (GFR ≥30 mL/min) Good (GFR ≥30 mL/min) Good (GFR ≥30 mL/min)
Cost (monthly) $8-$12 $4-$7 $4-$7 $10-$15 $15-$20 $15-$20 $15-$20

Quick Take

  • Indapamide (Lozol) is a thiazide‑like diuretic mainly used for hypertension and mild edema.
  • It offers a longer half‑life and smoother blood‑pressure control than many classic thiazides.
  • Key alternatives include Hydrochlorothiazide, Chlorthalidone, Furosemide, Spironolactone, Bumetanide, and Amiloride.
  • Decision factors: duration of action, electrolyte impact, kidney function, cost, and co‑existing conditions.
  • Overall, Indapamide shines for patients who need steady pressure control with fewer metabolic disturbances.

What Is Indapamide (Lozol)?

When treating hypertension, Indapamide is a thiazide‑like diuretic marketed as Lozol. It reduces sodium reabsorption in the distal tubule, prompting the kidneys to expel water and lower blood pressure.

Indapamide belongs to the class of low‑dose thiazide‑like agents first approved in 1985. Typical once‑daily dosing ranges from 1.25mg to 2.5mg for hypertension and up to 5mg for edematous states. Its half‑life of 14‑16hours provides a gentle, round‑the‑clock effect without the sharp peaks seen in older thiazides.

How Indapamide Works

The drug blocks the Na⁺/Cl⁻ cotransporter in the distal convoluted tubule, which diminishes sodium and water reabsorption. This process also triggers a modest vasodilation effect, contributing to blood‑pressure reduction beyond pure diuresis. Because it’s less potent at calcium loss, patients often experience fewer muscle cramps compared with classic thiazides.

Key Comparison Criteria

Before diving into the table, here’s a quick rundown of the factors that matter most when you’re weighing Indapamide against its peers:

  • Duration of action - Longer‑acting agents reduce the need for twice‑daily dosing.
  • Electrolyte profile - Some diuretics deplete potassium more aggressively.
  • Kidney safety - Certain drugs are safer for patients with reduced GFR.
  • Cost & insurance coverage - Generic availability drives out‑of‑pocket expense.
  • Primary indication - While all lower pressure, some are favored for heart‑failure, others for pure hypertension.

Side‑by‑Side Comparison

Indapamide vs Common Diuretics
Attribute Indapamide (Lozol) Hydrochlorothiazide Chlorthalidone Furosemide Spironolactone Bumetanide Amiloride
Drug class Thiazide‑like Thiazide Thiazide‑like Loop Potassium‑sparing Loop Potassium‑sparing
Typical daily dose 1.25‑2.5mg 12.5‑50mg 12.5‑25mg 20‑80mg 25‑100mg 0.5‑2mg 5‑10mg
Half‑life 14‑16h 6‑15h 40‑60h 2‑4h 24‑36h 1‑1.5h 6‑9h
Potassium impact Mild loss Moderate loss Moderate loss Significant loss Retains potassium Significant loss Retains potassium
Kidney safety (GFR<30ml/min) Generally safe Use with caution Use with caution Avoid unless essential Safe, monitor electrolytes Avoid Safe, monitor sodium
Primary uses Hypertension, mild edema Hypertension Hypertension, resistant Acute fluid overload, CHF Heart failure, hyperaldosteronism Severe edema, CHF Hypertension, adjunct in CHF
Typical cost (US generic, per month) $8‑$12 $4‑$7 $6‑$9 $12‑$20 $15‑$25 $14‑$22 $9‑$13
When Indapamide Is the Right Choice

When Indapamide Is the Right Choice

If you need a once‑daily pill that keeps blood pressure steady without dramatic swings in potassium, Indapamide often tops the list. It’s especially useful for patients who have experienced muscle cramps or low‑grade electrolyte disturbances on classic thiazides.

Because its half‑life stretches beyond 12hours, you’ll rarely hear of “mid‑day spikes” that sometimes prompt a second dose with Hydrochlorothiazide. For older adults or those on multiple meds, the smoother profile can mean fewer drug‑drug surprises.

Alternatives at a Glance

Hydrochlorothiazide (HCTZ) is the workhorse thiazide that many physicians first prescribe. It’s cheap and effective but can cause more noticeable potassium loss.

Chlorthalidone offers a longer duration than HCTZ, making it a favorite for resistant hypertension. Its potency, however, sometimes leads to greater sodium depletion.

Furosemide is a loop diuretic used when rapid fluid removal is required, such as in acute heart‑failure exacerbations. It’s powerful but can wreak havoc on potassium and calcium levels.

Spironolactone works by antagonizing aldosterone, sparing potassium while lowering pressure. It’s excellent for patients with heart‑failure or primary aldosteronism, yet hormonal side effects (e.g., gynecomastia) can limit use.

Bumetanide is another loop diuretic, roughly 40times more potent than Furosemide on a milligram basis. It’s reserved for severe edema when lower‑dose loops are insufficient.

Amiloride blocks sodium channels in the collecting duct, offering modest pressure reduction while preserving potassium. It’s typically added to other diuretics to blunt potassium loss.

Choosing the Best Diuretic for You

Start by listing your priorities:

  1. Do you need rapid fluid removal? Loop diuretics (Furosemide, Bumetanide) win.
  2. Is potassium preservation a deal‑breaker? Consider Spironolactone or Amiloride.
  3. Do you have chronic kidney disease? Indapamide and Chlorthalidone are generally safer than high‑dose loops.
  4. Are you on a tight budget? Hydrochlorothiazide is the cheapest, but the extra cost of Indapamide may be offset by fewer lab tests.
  5. Do you experience frequent muscle cramps? Indapamide’s milder calcium loss makes it a good fallback.

Discuss these points with your prescriber. In many cases, a trial period of 2‑4weeks helps gauge tolerability before committing to a long‑term regimen.

Safety, Interactions, and Monitoring

All diuretics can raise uric acid and trigger gout flares; keep an eye on serum uric acid if you have a history. Combine Indapamide with ACE inhibitors or ARBs for synergistic blood‑pressure control, but monitor creatinine and potassium closely.

Loop diuretics amplify the ototoxic risk of aminoglycoside antibiotics-avoid that combo unless absolutely necessary. Spironolactone interacts with potassium supplements and certain antifungals, demanding regular electrolyte checks.

Pregnancy and lactation considerations:

  • Indapamide is category C; use only if benefits outweigh risks.
  • Hydrochlorothiazide is also category B, generally safe in the second trimester.
  • Spironolactone is contraindicated in pregnancy due to anti‑androgen effects.

Cost & Access Overview (2025 US Market)

Insurance formularies often place Indapamide in a mid‑tier tier, costing $8‑$12 per month for a generic supply. Hydrochlorothiazide stays under $7, while Chlorthalidone hovers around $9. Loop agents like Furosemide and Bumetanide are pricier ($12‑$22) because they’re less commonly generic.

Many mail‑order pharmacies offer a 90‑day supply discount of up to 20% for Indapamide. If you’re uninsured, discount programs like GoodRx can shave $5 off a monthly bill.

Bottom Line

Indapamide (Lozol) shines when you crave steady pressure control without the potassium swings that classic thiazides sometimes cause. It’s not the cheapest option, but the smoother side‑effect profile can save you money on labs and doctor visits.

For patients needing fast fluid removal, loops remain the go‑to. If potassium preservation or hormonal side effects matter, Spironolactone or Amiloride may be better fits. Weigh your health goals, kidney function, and budget, then let your clinician tailor the final prescription.

Frequently Asked Questions

Frequently Asked Questions

Can I switch from Hydrochlorothiazide to Indapamide?

Yes, many doctors switch patients who experience cramps or low potassium on HCTZ. The change is usually done gradually, monitoring blood pressure and electrolytes for a couple of weeks.

Is Indapamide safe for people with chronic kidney disease?

Indapamide is generally safer than high‑dose loops for GFR>30ml/min. Below that threshold, doses should be reduced and kidney function rechecked frequently.

How does the cost of Indapamide compare to other diuretics?

Indapamide runs about $8‑$12 a month, a bit higher than Hydrochlorothiazide ($4‑$7) but cheaper than most loops. Insurance coverage and discount cards can narrow the gap.

Do I need regular blood tests while on Indapamide?

A baseline metabolic panel is recommended, then follow‑up labs after 2‑4 weeks to check potassium, sodium, and kidney function. If values stay stable, yearly checks are usually enough.

Can Indapamide be used during pregnancy?

It’s a categoryC drug, meaning it should only be used if the benefit outweighs the risk. Discuss alternatives with your obstetrician.

Prasham Sheth

Prasham Sheth

As a pharmaceutical expert, I have dedicated my life to researching and developing new medications to combat various diseases. With a passion for writing, I enjoy sharing my knowledge and insights about medication and its impact on people's health. Through my articles and publications, I strive to raise awareness about the importance of proper medication management and the latest advancements in pharmaceuticals. My goal is to empower patients and healthcare professionals alike, helping them make informed decisions for a healthier future.

View all posts

9 Comments

Arthur Verdier

Arthur Verdier

1 October 2025 - 14:59 PM

Oh sure, the whole "all diuretics are interchangeable" meme that the FDA pushes, because why bother with half‑life or potassium loss when you can just pick the cheapest pill, right?

Breanna Mitchell

Breanna Mitchell

7 October 2025 - 04:20 AM

Actually, the data shows indapamide's gentler potassium profile can be a real lifesaver for folks prone to hypokalemia.

Alice Witland

Alice Witland

12 October 2025 - 17:40 PM

Interesting table, though I’m still waiting for the part where they explain why doctors love prescribing the cheapest drug regardless of patient nuance.

Chris Wiseman

Chris Wiseman

18 October 2025 - 07:00 AM

When one contemplates the pharmaco‑dynamic tapestry that is woven by diuretic therapy, it becomes evident that indapamide occupies a singular niche, one that both transcends and complements the classic thiazide archetype; its half‑life, lingering between fourteen and sixteen hours, offers a pharmacokinetic steadiness that mitigates the peaks and troughs so often associated with hydrochlorothiazide's erratic profile; moreover, the modest potassium loss inherent to indapamide reduces the clinician's burden of vigilant electrolyte monitoring, thereby streamlining outpatient management; the drug's vasodilatory whisper, a subtle yet measurable adjunct to its natriuretic action, further distinguishes it from the more brute‑force loops such as furosemide, whose rapid onset is counterbalanced by a propensity for profound electrolyte depletion; consider also the economic dimension, where a monthly cost of eight to twelve dollars, while not the cheapest, spares patients the hidden expenses of frequent lab draws and potential hospitalizations due to dyskalemia; the renal safety profile, deemed good for glomerular filtration rates above thirty, aligns well with the demographic of hypertensive patients who frequently present with mild chronic kidney disease; in contrast, the older thiazides, despite their lower price tag, often demand dose adjustments and heightened vigilance as renal function wanes; one must also weigh the therapeutic synergy of indapamide when paired with ACE inhibitors or ARBs, a combination that has demonstrated additive blood pressure reductions without amplifying adverse events; the clinical trials, though not as abundant as those for furosemide, nonetheless furnish a credible evidence base for indapamide's efficacy in both hypertension and modest edema; the dosage convenience of once‑daily administration cannot be overstated, especially in an era where medication adherence remains a pervasive challenge; furthermore, the comparatively mild impact on calcium excretion curtails the risk of secondary hyperparathyroidism, a subtle benefit often overlooked; patients with a proclivity for muscle cramps may find indapamide a gentler ally than its thiazide cousins; from a prescribing perspective, the modest uptick in cost may be justified by the reduction in ancillary healthcare utilization; the pharmacological elegance of indapamide, therefore, lies not merely in its primary mechanism but in the cascade of secondary advantages it imparts; ultimately, the decision matrix should incorporate these multilayered considerations rather than defaulting to the cheapest generic on the shelf.

alan garcia petra

alan garcia petra

23 October 2025 - 20:20 PM

Bottom line: it works well and isn’t hard on the kidneys.

Allan Jovero

Allan Jovero

29 October 2025 - 09:40 AM

In accordance with the presented data, it is evident that indapamide provides a balanced electrolyte profile while maintaining adequate antihypertensive efficacy.

Andy V

Andy V

3 November 2025 - 23:00 PM

Look, if you ignore the potassium issue just to save a buck, you’re asking for trouble, plain and simple.

Tammie Sinnott

Tammie Sinnott

9 November 2025 - 12:20 PM

Indapamide swoops in like a quiet hero, saving blood pressure without the thunderous side‑effects of its louder cousins.

Michelle Wigdorovitz

Michelle Wigdorovitz

15 November 2025 - 01:40 AM

I’ve been on indapamide for a few months, and honestly, my legs feel less puffy and I haven’t had that annoying low‑potassium dip.

Write a comment